pdufa date for tirzepatide RTTNews | BIG WEEK AHEAD IN BIOTECH We're tracking [2] dates, [1] phase readouts, and [1] events — including: → AZN: FDA decision July 7, Tirzepatide: First Approval | Drugs

Vardenafil Sublingual Troche Supports fast on-demand performance with convenient sublingual dosing

Injectables: While GLP-1s are currently mostly injectables, their superior results are convincing patients to move away from daily pills

Train Your Staff Proper training is crucial

Puglisi S, Rossini A, Poli R et al (2021) Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system

The absence of knowledge regarding what causes PD has two major consequences: it is not possible to advise men regarding risk factors and how the disease may be prevented and treatments remain focused on the alleviation of symptoms rather than on addressing causal mechanisms

Increasing the doses of tirzepatide should be guided by a doctor and done in increments of 2.5 mg